Results 71 to 80 of about 2,328 (144)

Preliminary performance of the VIDAS TB-IGRA as an aid in the diagnosis of individuals infected with Mycobacterium tuberculosis

Journal of Clinical Microbiology
This preliminary study compares VIDAS TB-IGRA (bioMérieux, Marcy-l'Etoile, France) with the established QuantiFERON-TB Gold Plus (QFT-Plus) (Qiagen, Hilden, Germany) to evaluate diagnostic performance for the diagnosis of individuals infected with ...
Potiandi Serge Diagbouga, Arthur Diakourga Djibougou, Camille Pease, Ariana Alcaide, Audrey Berthoux, Natalie Bruiners, Daniela Maria Cirillo, Ardjouma Combary, Nadine Falchero, Deborah Handler, Antoinette Kaboré, Alfred Lardizabal, Amanda Lopes, Marissa Loubet, Philippe Manivet, Clemence Margain, Valerie Meunier, Faiza Mougari, Alberta Onyuka, Sophie Rivoiron, Tani Sagna, Mathilde Sanvert, Léon Sawadogo, Jacques Simporé, Emmanuelle Cambau, Maria Laura Gennaro   +25 more
doaj   +1 more source

Sensitivity and characteristics associated with positive QuantiFERON-TB Gold-Plus assay in children with confirmed tuberculosis.

PLoS ONE, 2019
BACKGROUND:Although QuantiFERON-TB Gold Plus (QFT-Plus), a new interferon-gamma release assay, has shown good performance in adults, little data is available in children. METHODS:De-identified data from TB-suspected patients age
Duc T Nguyen, Ha Phan, Trang Trinh, Hang Nguyen, Ha Doan, Nam Pham, Hung Nguyen, Hanh Nguyen, Hung V Nguyen, Hoi V Le, Nhung Nguyen, Edward A Graviss   +11 more
doaj   +1 more source

Screening for Latent Tuberculosis Infection in People Living with HIV: TUBHIVIT Project, a Multicenter Italian Study

Viruses
Background: The coexistence of HIV infection and latent tuberculosis infection (LTBI) presents a significant public health concern due to the increased risk of tuberculosis (TB) reactivation and progression to active disease.
Luca Pipitò, Elena Delfina Ricci, Paolo Maggi, Giuseppe Vittorio De Socio, Giovanni Francesco Pellicano, Marcello Trizzino, Raffaella Rubino, Alessandra Lanzi, Lorenzo Crupi, Ilaria Capriglione, Nicola Squillace, Giuseppe Nunnari, Antonio Di Biagio, Paolo Bonfanti, Antonio Cascio   +14 more
doaj   +1 more source

Serial Assays of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold-Plus in Subjects Exposed to Patients with Active Tuberculosis

Annals of Laboratory Medicine, 2020
Hee-Won Moon, Ahram Yi, Sumi Yoon, Hanah Kim, Hee-Jung Chung, Mina Hur, Yeo-Min Yun, Kwang Ha Yoo   +7 more
openaire   +3 more sources

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Latent Tuberculosis Infection among Household Contacts of Tuberculosis Patients, Healthcare Workers, and Tuberculosis Patients Using QuantiFERON-tuberculosis Gold Plus and Tuberculin Skin Test in a Tertiary Care Hospital Setting Bhubaneswar, Odisha – A Cross-sectional Study

Journal of Global Infectious Diseases
Introduction: Contacts of tuberculosis (TB) patients have an increased risk of latent TB infection (LTBI). Currently, it is diagnosed using one of the two methods: Tuberculin skin test (TST) or QuantiFERON-TB Gold Plus.
Braja Sundar Barik, Chinmay Divyadarshi Kar, Shritam Das, Tahziba Hussain, Sasmita Nayak, Arun Kumar Sahu, Sooman Sundaray, Sanghamitra Pati   +7 more
doaj   +1 more source

UEG Week 2025 Poster Presentations

United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley   +1 more source

Publication Only

HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Experiences from Ukraine in expanding TB infection diagnosis and treatment, including for drug-resistant TB

IJTLD Open
BACKGROUND: Ukraine faces intersecting epidemics of HIV and drug-resistant TB (DR-TB), with high risk of progression from TB infection to active disease.
V. Shukatka, L. Skoklyuk, M. Germanovych, A. Bogdanov, T. Ivanenko, N. Zherebko, E. Klinkenberg, G. Dravniece   +7 more
doaj   +1 more source

QuantiFERON-TB Gold Plus for screening and monitoring latent tuberculosis infection in spondyloarthritis patients

The Journal of Infection in Developing Countries
Introduction: The optimal frequency of rescreening for latent tuberculosis infection (LTBI) in patients with inflammatory arthritis on biologic/targeted-synthetic disease modifying anti-rheumatic drugs (b/ts-DMARDs) is uncertain. We aimed to evaluate the impact of LTBI re-screening using the QuantiFERON-TB Gold Plus (QFT-Plus; QIAGEN, Germantown, USA ...
Zehra Ozsoy, Adem Ozdemir, Mustafa Ekici, Emre Bilgin, Asena Eken, Zeynep Saribas, Ahmet C Inkaya, Deniz Koksal, Burcin Sener, Ihsan Ertenli, Omer Karadag, Levent Kilic   +11 more
openaire   +3 more sources